Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Aston Villa takes the first steps to sign the La Liga center back for 25 million euros

Aston Villa have developed some taste for the Spanish market since the arrival of Unai Emery and sporting director Monchi, and the Villains could be back in the hunt for a central defender before long. Monchi was seen last weekend at Rayo Vallecano’s win over Celta Vigo on Friday, but then attended Sevilla’s draw against Valencia.

The reason was not only to see his old team, but also to see Loic Bade. According to Relevo, Aston Villa have taken the first steps to sign the French defender, who was signed by Monchi during his time at Ramón Sánchez Pizjuán. Sevilla’s current sporting director, Víctor Orta, denied that Monchi was at Sevilla’s training ground on Tuesday, but did state that “there was a market, but no offer” for Bade.

The Nervionenses remain firm in their position that they will not accept less than 25 million euros for Bade. Last summer, Roma were rejected late in the market, as Sevilla demanded €30 million, due to their offer arriving late in the market, and Bade, happy in Andalusia, signed a new deal until 2029. He is aware that a move to Villa would be of great financial benefit to him, but will not force a move.

Bade, 24, had a brief and unsuccessful spell at Nottingham Forest before joining Sevilla, but continued his development at Ramón Sánchez Pizjuán, becoming one of La Liga’s best defenders. As Aston Villa attempt to sign Diego Carlos, Bade looks likely to be his replacement.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.